Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phillip J Gray

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Asian Journal of Andrology|March 28, 2015
From bench to bedside: bipolar androgen therapy in a pilot clinical studyQing Zhang, Phillip J Gray
Asian Journal of Andrology|December 27, 2011
The importance of combined radiation and endocrine therapy in locally advanced prostate cancerPhillip J Gray, William U Shipley
Nature Reviews. Urology|February 13, 2013
Prostate cancer: Proton therapy--revolutionary advance or diminishing returns?Phillip J Gray, Jason A Efstathiou
Current Urology Reports|April 3, 2013
Proton beam radiation therapy for prostate cancer-is the hype (and the cost) justified?Phillip J Gray, Jason A Efstathiou
JAMA Oncology|July 17, 2015
Dose-Escalated Radiotherapy for Prostate Cancer: Is the Sky the Limit?Phillip J Gray, Anthony L Zietman
The Lancet. Oncology|February 24, 2015
Androgen deprivation with radiotherapy: how long is long enough?Phillip J Gray, Anthony L Zietman
Cancer Treatment Reviews|March 31, 2009
DNA minor groove binders: back in the grooveXuemei Cai, Phillip J Gray, Daniel D Von Hoff
Annals of the New York Academy of Sciences|November 6, 2007
Extracellular heat shock proteins in cell signaling and immunityStuart K Calderwood, Salamatu S Mambula, Phillip J Gray
Asian Journal of Andrology|February 26, 2013
The opportunity cost of androgen suppression in locally advanced prostate cancerPhillip J Gray, Jason A Efstathiou, William U Shipley
Cancer Research|December 20, 2007
Targeting Cdc37 inhibits multiple signaling pathways and induces growth arrest in prostate cancer cellsPhillip J Gray, Mary Ann Stevenson, Stuart K Calderwood
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Asian Journal of Andrology|March 28, 2015
From bench to bedside: bipolar androgen therapy in a pilot clinical studyQing Zhang, Phillip J Gray
Asian Journal of Andrology|December 27, 2011
The importance of combined radiation and endocrine therapy in locally advanced prostate cancerPhillip J Gray, William U Shipley
Nature Reviews. Urology|February 13, 2013
Prostate cancer: Proton therapy--revolutionary advance or diminishing returns?Phillip J Gray, Jason A Efstathiou
Current Urology Reports|April 3, 2013
Proton beam radiation therapy for prostate cancer-is the hype (and the cost) justified?Phillip J Gray, Jason A Efstathiou
JAMA Oncology|July 17, 2015
Dose-Escalated Radiotherapy for Prostate Cancer: Is the Sky the Limit?Phillip J Gray, Anthony L Zietman
The Lancet. Oncology|February 24, 2015
Androgen deprivation with radiotherapy: how long is long enough?Phillip J Gray, Anthony L Zietman
Cancer Treatment Reviews|March 31, 2009
DNA minor groove binders: back in the grooveXuemei Cai, Phillip J Gray, Daniel D Von Hoff
Annals of the New York Academy of Sciences|November 6, 2007
Extracellular heat shock proteins in cell signaling and immunityStuart K Calderwood, Salamatu S Mambula, Phillip J Gray
Asian Journal of Andrology|February 26, 2013
The opportunity cost of androgen suppression in locally advanced prostate cancerPhillip J Gray, Jason A Efstathiou, William U Shipley
Cancer Research|December 20, 2007
Targeting Cdc37 inhibits multiple signaling pathways and induces growth arrest in prostate cancer cellsPhillip J Gray, Mary Ann Stevenson, Stuart K Calderwood
Pageof 4